Today is the World Blood Cancer Day, an event to show solidarity to patients and raise awareness for the need of better therapies to treat these cancers – which are … Continue Reading It’s Blood Cancer Day, how is Biotech fixing it?
It sounds like a lot of fun, but DNA legos are serious: they represent the core concept of synthetic biology, a field with the potential to solve major issues in … Continue Reading Building Life from DNA Legos, a Review of Synthetic Biology
Brain diseases are hard to treat, but biotechs are harnessing a variety of techniques, including immunotherapy and gene therapy, to target neurodegenerative disorders. When Eli Lilly announced that solanezumab, a … Continue Reading Biologicals on the Brain: Biotech in Neurodegenerative Disease
Juno’s JCAR015 study came to a halt for the second time this year after two more patient deaths. But despite the bad news, hopes for CAR-T therapies remain high. Juno … Continue Reading What do the CAR-T Patient Deaths Mean for the Future of the Field?
With 422 million people suffering from diabetes, the disease has become an epidemic. There’s still no cure and medicine is struggling to provide an efficient solution. However, from needle-free glucose … Continue Reading Can Biotech Stop the Diabetes Epidemic? Reviewing the Hottest Technology
With last month’s FDA approval, Ocrevus (ocrelizumab), became the first drug for primary-progressive multiple sclerosis. Roche may be the first, but others in the biotech community are also working hard … Continue Reading How Biotech is Mastering Multiple Sclerosis: A Review
Since 2014, investment in Non-Alcoholic SteatoHepatitis (NASH) has taken off with a fervor reminiscent of immuno-oncology. What’s it all about? Jean-Christophe Marcoux “NASH is a well-recognized health emergency,” says Jean-Christophe … Continue Reading Not to be Underestimated: What’s the Hype around NASH?
Just 2% of experimental pain treatments clear Phase II. Why is this challenge so great, and which biotechs are gunning for Phase III and beyond? Dating back at least to … Continue Reading A Painful Case: How Biotech is trying to Break Through in Analgesia
When the Japanese researcher Shinya Yamanaka managed to reprogram adult cells into an embryonic-like state to yield induced pluripotent stem cells (iPSCs), this was supposed to herald a revolution in … Continue Reading Regenerating the Body With Stem Cells – Hype or Hope?
Immunotherapies have been taking the biotech world by storm. Among these are cancer vaccines, which are directed at solid tumors and aim to boost patients’ immune systems to fight cancer. … Continue Reading Boosting the Immune System with Vaccines to Fight Cancer: A Review
The field of genetics has long been an object of global fascination, beginning with Mendel’s pea plant experiments in the 19th century and peaking when the human genome was sequenced … Continue Reading The Next Generation of Genetic Medicine: A Review of Epigenetics
You’ve certainly heard about antibodies, peptides and even DNA as therapeutics, but what about RNA? In this review, we paint an overview of what’s up in a young field that … Continue Reading RNA as a Therapy: Reviewing the Future Generation of Therapeutics
May 5, 2017, saw the first FDA approval for an amyotrophic lateral sclerosis (ALS) drug in 20 years, when Edaravone/Radicava, developed by Japanese company MT Pharma, received orphan drug registration. … Continue Reading How Close Are We to Curing ALS? A Review of Biotech’s Efforts
Over 10,000 human diseases are caused by exactly one faulty gene. Gene therapy promises to fix each of them. Here’s a review of biotech’s progress. Biotech is arguably built on genetic … Continue Reading Reviewing Gene Therapy: How Close is Biotech to Genetic Cures?
The emergence of CRISPR/Cas9 technologies has enabled almost unlimited gene editing opportunities. Not only could it be used as a therapeutic tool, the genome editing tool could kickstart a revolution … Continue Reading CRISPR/Cas9: Could the Gene Editing Technology be the Future of Drug Discovery?
Experts say hemophilia treatment is at a ‘precipice of a therapeutic revolution.’ From antibodies to gene therapy, here are some of the most innovative technologies in the field that might … Continue Reading How is Biotech Innovating to Treat Hemophilia? Let’s Review